Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,260 Cr
up ₹179 Cr vs Mar 2025
- Stocks held
- 37
- up 1 vs Mar 2025
- Top 10 weight
- 60.3%
- of the portfolio in its ten largest
- Cash & debt
- 0.3%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 12
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In April 2025 it disclosed 37 stocks worth ₹8,260 Cr, up ₹179 Cr from Mar 2025. Its largest positions were Sun Pharmaceutical Industries Limited (13.9%), Divi's Laboratories Limited (9.6%), Lupin Limited (6.3%); the ten largest together made up 60.3% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 76.4% of its equity. Cash and debt stood at 0.3%. Compared with Mar 2025 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
85%
Top-10 weight is higher than 85% of peers
Breadth
34%
Holds more stocks than 34% of peers
Cash
4%
Holds more cash than 4% of peers
Holdings in April 2025
Download CSVEvery line the fund disclosed, with the change against Mar 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.88%
- Δ weight
- up 0.45 pts
- Value
- ₹1,146 Cr
- Δ value
- up ₹61.1 Cr
- Status
- Added
- Weight
- 9.57%
- Δ weight
- up 0.29 pts
- Value
- ₹791 Cr
- Δ value
- up ₹40.5 Cr
- Status
- Added
- Weight
- 6.30%
- Δ weight
- down 0.97 pts
- Value
- ₹521 Cr
- Δ value
- down ₹67.2 Cr
- Status
- Trimmed
- Weight
- 6.01%
- Δ weight
- up 0.29 pts
- Value
- ₹496 Cr
- Δ value
- up ₹34.5 Cr
- Status
- Added
- Weight
- 5.48%
- Δ weight
- up 0.17 pts
- Value
- ₹453 Cr
- Δ value
- up ₹23.4 Cr
- Status
- Added
- Weight
- 5.25%
- Δ weight
- up 0.06 pts
- Value
- ₹434 Cr
- Δ value
- up ₹14.5 Cr
- Status
- Added
- Weight
- 3.63%
- Δ weight
- up 0.03 pts
- Value
- ₹300 Cr
- Δ value
- up ₹8.5 Cr
- Status
- Added
- Weight
- 3.54%
- Δ weight
- up 0.13 pts
- Value
- ₹292 Cr
- Δ value
- up ₹16.7 Cr
- Status
- Added
- Weight
- 3.43%
- Δ weight
- down 0.10 pts
- Value
- ₹283 Cr
- Δ value
- down ₹1.9 Cr
- Status
- Trimmed
- Weight
- 3.23%
- Δ weight
- down 0.23 pts
- Value
- ₹267 Cr
- Δ value
- down ₹12.8 Cr
- Status
- Trimmed
- Weight
- 3.14%
- Δ weight
- up 0.03 pts
- Value
- ₹260 Cr
- Δ value
- up ₹8 Cr
- Status
- Added
- Weight
- 3.04%
- Δ weight
- up 0.05 pts
- Value
- ₹251 Cr
- Δ value
- up ₹9.8 Cr
- Status
- Added
- Weight
- 2.59%
- Δ weight
- down 0.42 pts
- Value
- ₹214 Cr
- Δ value
- down ₹29.4 Cr
- Status
- Trimmed
- Weight
- 2.53%
- Δ weight
- up 0.09 pts
- Value
- ₹209 Cr
- Δ value
- up ₹11.7 Cr
- Status
- Added
- Weight
- 2.38%
- Δ weight
- up 0.20 pts
- Value
- ₹196 Cr
- Δ value
- up ₹20.6 Cr
- Status
- Added
- Weight
- 2.15%
- Δ weight
- down 0.04 pts
- Value
- ₹178 Cr
- Δ value
- up ₹37 L
- Status
- Held
- Weight
- 2.02%
- Δ weight
- up 0.01 pts
- Value
- ₹167 Cr
- Δ value
- up ₹4.7 Cr
- Status
- Added
- Weight
- 2.00%
- Δ weight
- up 0.05 pts
- Value
- ₹166 Cr
- Δ value
- up ₹7.6 Cr
- Status
- Added
- Weight
- 1.95%
- Δ weight
- down 0.06 pts
- Value
- ₹161 Cr
- Δ value
- down ₹1.1 Cr
- Status
- Trimmed
- Weight
- 1.94%
- Δ weight
- down 0.01 pts
- Value
- ₹160 Cr
- Δ value
- up ₹2.6 Cr
- Status
- Added
- Weight
- 1.88%
- Δ weight
- up 0.39 pts
- Value
- ₹155 Cr
- Δ value
- up ₹35 Cr
- Status
- Added
- Weight
- 1.66%
- Δ weight
- up 0.03 pts
- Value
- ₹137 Cr
- Δ value
- up ₹5 Cr
- Status
- Added
- Weight
- 1.65%
- Δ weight
- up 0.08 pts
- Value
- ₹137 Cr
- Δ value
- up ₹9.2 Cr
- Status
- Added
- Weight
- 1.33%
- Δ weight
- down 0.13 pts
- Value
- ₹110 Cr
- Δ value
- down ₹7.9 Cr
- Status
- Trimmed
- Weight
- 1.28%
- Δ weight
- up <0.01 pts
- Value
- ₹106 Cr
- Δ value
- up ₹2.4 Cr
- Status
- Added
- Weight
- 1.21%
- Δ weight
- down 0.14 pts
- Value
- ₹99.7 Cr
- Δ value
- down ₹9.2 Cr
- Status
- Trimmed
- Weight
- 1.15%
- Δ weight
- up 0.13 pts
- Value
- ₹94.8 Cr
- Δ value
- up ₹12.7 Cr
- Status
- Added
- Weight
- 0.92%
- Δ weight
- down 0.04 pts
- Value
- ₹75.7 Cr
- Δ value
- down ₹1.4 Cr
- Status
- Trimmed
- Weight
- 0.89%
- Δ weight
- down 0.08 pts
- Value
- ₹73.5 Cr
- Δ value
- down ₹4.5 Cr
- Status
- Trimmed
- Weight
- 0.86%
- Δ weight
- down 0.15 pts
- Value
- ₹71.3 Cr
- Δ value
- down ₹10.4 Cr
- Status
- Trimmed
- Weight
- 0.67%
- Δ weight
- down 0.01 pts
- Value
- ₹55.6 Cr
- Δ value
- up ₹47 L
- Status
- Added
- Weight
- 0.52%
- Δ weight
- down 0.01 pts
- Value
- ₹42.7 Cr
- Δ value
- down ₹6 L
- Status
- Held
- Weight
- 0.48%
- Δ weight
- up <0.01 pts
- Value
- ₹39.5 Cr
- Δ value
- up ₹1.2 Cr
- Status
- Added
- Weight
- 0.37%
- Δ weight
- down 0.03 pts
- Value
- ₹30.8 Cr
- Δ value
- down ₹1.5 Cr
- Status
- Trimmed
- Weight
- 0.37%
- Δ weight
- up <0.01 pts
- Value
- ₹30.3 Cr
- Δ value
- up ₹80 L
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 0.29%
- Δ weight
- down 0.25 pts
- Value
- ₹24.1 Cr
- Δ value
- down ₹19.9 Cr
- Status
- Trimmed
- Weight
- 0.21%
- Δ weight
- down 0.03 pts
- Value
- ₹17 Cr
- Δ value
- down ₹1.8 Cr
- Status
- Trimmed
- Weight
- 0.20%
- Δ weight
- up 0.20 pts
- Value
- ₹16.4 Cr
- Δ value
- up ₹16.4 Cr
- Status
- New
What changed, Mar 2025 to Apr 2025
New New positions (1)
- Akums Drugs and Pharmaceuticals Limited0.2% · ₹16.4 Cr
Exited Exited (0)
None.
Added Biggest additions
- Sun Pharmaceutical Industries Limitedup ₹61.1 Cr (+0.45% pts)
- Divi's Laboratories Limitedup ₹40.5 Cr (+0.29% pts)
- Thyrocare Technologies Limitedup ₹35 Cr (+0.39% pts)
- Cipla Limitedup ₹34.5 Cr (+0.29% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Mar 2025, the weight rose most in Healthcare Services (+0.6 pts) and Retailing (+0.1 pts), and fell most in Pharmaceuticals & Biotechnology (−0.7 pts).
- Healthcare Services18.9% → 19.6%+0.6 pts
- Retailing3.4% → 3.6%+0.1 pts
- Pharmaceuticals & Biotechnology77.1% → 76.4%−0.7 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Apr 2022 | Apr 2024 | Oct 2024 | Jan 2025 | Mar 2025 | Apr 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 78.4% | 79.0% | 78.7% | 77.0% | 77.1% | 76.4% |
| Healthcare Services | 19.3% | 17.0% | 18.2% | 19.2% | 18.9% | 19.6% |
| Retailing | — | 3.1% | 2.5% | 3.2% | 3.4% | 3.6% |
| Pharmaceuticals | 1.8% | 0.9% | 0.7% | 0.6% | 0.5% | 0.5% |
Allocation in Apr 2025change vs Mar 2025
- Pharmaceuticals & Biotechnology (26)76.4%▼ 0.7 pts
- Healthcare Services (9)19.6%▲ 0.6 pts
- Retailing (1)3.6%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Apr 2025
0.3%
▼ 0.3 pts vs Mar 2025
- Cash alone
- 0.3%
- cash and net receivables
- A year earlier
- 3.8%
- Apr 2024 · now ▼ 3.6 pts
- Last 12 months
- 0.3% – 4.4%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.